Murine Model of Disseminated Fusariosis: Evaluation of the Fungal Burden by Traditional CFU and Quantitative PCR

Mycopathologia

Volumn 176, Issue 3-4, 2013, Pages 219-224

  González, Gloria M ^a   Márquez, Jazmín ^a   Treviño Rangel, Rogelio de J ^a   Palma Nicolás, José P ^a   Garza González, Elvira ^a   Ceceñas, Luis A ^b   Gerardo Gonzalez J ^b  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Medicina UANL   (Mexico)

Author keywords

CFU; Fungal burden; Fusariosis; Murine model; Quantitative PCR

Indexed keywords

ANIMALIA; FUNGI; FUSARIUM SOLANI; MURINAE; MUS;

ANIMAL; ARTICLE; BACTERIAL COUNT; BAGG ALBINO MOUSE; DISEASE MODEL; FUSARIOSIS; FUSARIUM; GENETICS; GROWTH, DEVELOPMENT AND AGING; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; KIDNEY; MALE; METHODOLOGY; MICROBIOLOGY; MOUSE; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; TIME;

ANIMALS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FUSARIOSIS; FUSARIUM; KIDNEY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN; TIME FACTORS;

EID: 84884902018     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-013-9687-3     Document Type: Article

References (24)

1. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20: 695-704.
2. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect Dis. 2004;10(suppl 1): 67-75.
3. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994;28(suppl 1): 7-15.
4. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999;1: 247-61.
5. Girmenia C, Pagano L, Corvatta L, Mele L, del Favero A, Martino P. The epidemiology of fusariosis in patients with haematological diseases. Br J Haematol. 2000;111: 272-6.
6. Pontón J, Rüchel R, Clemons KV, Coleman DC, Grillot R, Guarro J, Aldebert D, Ambroise-Thomas P, Cano J, Carrillo-Muñoz AJ, Gené J, Pinel C, Stevens DA, Sullivan DJ. Emerging pathogens. Med Mycol. 2000;38(suppl 1): S225-36.
7. Mayayo E, Pujol I, Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol. 1999;48: 363-6.
8. Azor M, Gene J, Cano J, Guarro J. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother. 2007;51: 1500-3.
9. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. Isolates identified by molecular methods. J Antimicrob Chemother. 2008;61: 805-9.
10. O′Donnell K, Sutton DA, Fothergill A, McCarthy D, Rinaldi MG, Brandt ME, Zhang N, Geiser DM. Molecular phylogenetic, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008;46: 2477-90.
11. Nucci M, Marr KA, Queiroz-Telles F, Martins CA, Trabasso P, Costa S, Voltarelli JC, Colombo AL, Imhof A, Pasquini R, Maiolino A, Souza CA, Anaissie E. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004;38: 1237-42.
12. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003;36: 1122-31.
13. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006;42: 1398-403.
14. Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ, Loebenberg D, Rex JH. Treatment of murine fusariosis with SCH56592. Antimicrob Agents Chemother. 1999;43: 589-91.
15. Spellberg B, Schwartz J, Fu Y, Avanesian V, Adler-Moore J, Edwards JE Jr, Ibrahim AS. Comparison of antifungal treatments for murine fusariosis. J Antimicrob Chemother. 2006;58: 973-9.
16. Ruíz-Cendoya M, Mariné M, Guarro J. Combined therapy in treatment of murine infection by Fusarium solani. J Antimicrob Chemother. 2008;62: 543-6.
17. Wiederhold NP, Najvar LK, Bocanegra R, Graybill JR, Patterson TF. Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani. Antimicrob Agents Chemother. 2010;54: 1055-9.
18. Nelson PE, Tousson TA, Marasas WFO. Fusarium species: an illustrated manual for identification. University Park, PA: Pennsylvania State University Press; 1983.
19. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101: 1005-13.
20. Doyle JJ, Doyle JL. A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem Bull. 1987;19: 11-5.
21. Cullings KW. Design and testing of a plant-specific PCR primer for ecological and evolutionary studies. Mol Ecol. 1992;1: 233-40.
22. Jaeger EE, Carroll NM, Choudhury S, Dunlop AA, Towler HM, Matheson MM, Adamson P, Okhravi N, Lightman S. Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol. 2000;38: 2902-8.
23. Walsh TJ, McEntee C, Dixon DM. Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans. J Clin Microbiol. 1987;25: 931-2.
24. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12: 310-50.